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SI Materials and Methods
Protein Expression and Purification. All mutant proteins were
generated using Quikchange Mutagenesis protocol (Stratagene)
and purified identically to theWT protein. HIS6-tagged Get1-CD
and Get2-CD (both in a pET33b expression vector) were in-
duced at log phase for 3 h at 37 °C with 0.8 mM isopropyl β-D-1-
thiogalactopyranoside. Overexpressed protein in clarified lysate
was purified by nickel-nitrilotriacetic acid (Ni-NTA) affinity
chromatography followed by thrombin digestion to remove the
HIS6 tag. Get2-CD was further purified by gel filtration chro-
matography on a Superdex200 column (GE Healthcare).
Get1-CD was further purified by gel filtration chromatogra-
phy on a superose 12 column (GE Healthcare). HIS6-tagged
mini-Get1/2 and mini-Get1/2RERR (1) were expressed for 3 h at
37 °C and purified by Ni-NTA affinity chromatography. To ob-
tain stoichiometric complexes, partially purified proteins were
further purified with a 125-mL Superdex75 gel filtration column
(GE Healthcare). Full-length Get1 and Get2 were expressed
identically to those in ref. 2 using the overnight autoinduction
system (Novagen) in terrific broth (TB) media (3). For purifi-
cation, Get1 and Get2 (20–30 g dry weight cell pellet) were re-
suspended in buffer A (50 mM Hepes, pH 8.0, 500 mM NaCl,
10% glycerol) containing protease inhibitor mixture (Roche)
and lysed by French press. Unbroken cells were removed by
centrifugation at 12,000 × g for 20 min, and the supernatant was
ultracentrifuged (Ti45; 200,000 × g for 50 min). The resulting
membrane pellet was washed in buffer A, resuspended in buffer
A with 0.5% lauryldimethylamine-oxide (LDAO) and 20 mM
imidazole using a dounce homogenizer, and incubated for 1 h
under gentle agitation. Detergent-solubilized membrane was
clarified by ultracentrifugation in a Ti45 as above, and the
supernatant was subjected to Ni-NTA chromatography in
buffer A with 0.1% LDAO and 20 mM imidazole. After ex-
tensive washing, HIS6-tagged Get1 or Get2 was eluted in
buffer A with 0.1% LDAO and 200 mM imidazole and im-
mediately flash frozen in liquid nitrogen. All proteins (with
the exception of full-length Get1 and Get2) were exchanged
into Get3 assay buffer in the gel filtration step.
Fluorescence Labeling. Get4/5 (C177T/S48C) was labeled with
thiol-reactive acrylodan. Get1-CD–Q62C and Get2-CD–T34C
were labeled with maleimide derivatives of either coumarin
(DACM) or fluorescein. Proteins were dialyzed in labeling
buffer (50 mM KHEPES, pH 7.0, 300 mM NaCl) and treated
with 2 mM TCEP to reduce the disulfide bonds. The labeling
reaction was carried out using a 10- to 30-fold excess of dye over
protein. The reaction was incubated overnight at 4 °C and
stopped by adding 2 mM DTT. Excess dye was removed by gel
filtration using Sephadex G-25 (Sigma) (4).
Fluorescence Measurements.
Get4/5 equilibrium measurements. Measurements using acrylodan-
labeled Get4/5 were based on an environmental sensitive readout.
Samples were excited at 370 nm, and fluorescence emission at 490
nm was monitored. For all titrations, Get4/5FL was held constant
(50–200 nM), and Get3 concentration was varied. Incubation
time was 10 min, and nucleotide was present at 2 mM wherever
applicable. Observed fluorescence values (Fobsd) were plotted as
a function of Get3 concentration and fit to Eq. S1,
Fobsd =F0 +F1
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in which Fobsd is the observed fluorescence, F0 is the initial fluo-
rescence value, F1 is the maximum fluorescence change at satu-
rating Get3 concentrations, and Kd is the equilibrium dissocia-
tion constant of the complex.
Get4/5 association and dissociation kinetics. All rate measurements
were performed on a Kintek stopped flow apparatus. For asso-
ciation rate measurements, acrylodan-labeled Get4/5 was held
constant at 0.2 μM, Get3 concentration was varied as indicated,
and ATP was present at 2 mM. Observed rate constants (kobsd)
were plotted as a function of Get3 concentration and fit to
Eq. S2,
kobsd = kon½Get3+ koff ; [S2]
in which kon is the association rate constant, and koff is the
dissociation rate constant.
For dissociation rate measurements, a pulse-chase experiment
was used. A complex between acrylodan-labeled Get4/5 (at 0.15
μM) and Get3 (at 0.3 μM) was preformed by incubation in 2 mM
ATP for 10 min followed by the addition of unlabeled Get4/5 at
6 μM as the chase to initiate Get3–Get4/5 dissociation. The time
course for change in fluorescence (Fobsd) was fit to a double
exponential function (Eq. S3),
Fobsd =Fe +ΔF1 × e−kfastt +ΔF2 × e−kslowt; [S3]
in which Fe is the fluorescence when the reaction reaches equi-
librium, ΔF1 and kfast are the magnitude and rate constant of the
fluorescence change in the fast phase, and ΔF2 and kslow are
the magnitude and rate constant of the fluorescence change in
the slow phase.
Equilibrium measurements of Get3 binding to Get1-CD and Get2-CD.
Measurements using fluorescein-labeled Get1-CD or Get2-CD
were based on a fluorescence anisotropy readout (Fig. 3). Samples
were excited at 450 nm, and fluorescence emission at 518 nm was
monitored. For all titrations, Get1-CD or Get2-CD was held
constant at 200 nM, and Get3 or Get3/TA concentration was
varied. Incubation time was 5–10 min depending on protein
concentration, and nucleotide was present at 2 mM. Observed
anisotropy values were plotted as a function of Get3 concentra-
tion and fit to Eq. S1, with anisotropy values replacing the fluo-
rescence values.
Equilibrium measurements of Get3/TA binding to Get1/2-mini. Measure-
ments are based on the fluorescence change of DACM-labeledGet1
(denoted by *) in Get1*/2-mini. Samples were excited at 380 nm,
and fluorescence emission at 470 nm was monitored. For all titra-
tions, Get1*/2-mini was held constant at 200 nM, and Get3/TA
concentration was varied. Incubation time was 10 min. Observed
fluorescence values (Fobsd) were plotted as a function of Get3/TA
concentration and fit to Eq. S1.
Get1-CD dissociation kinetics from Get3. Measurements used a pulse-
chase setup on the stopped flow apparatus (Kintek); 150 nM
DACM-labeled Get1-CDwas preincubated with 350 nMGet3 for
15 min and chased by addition of either 2 mM ATP or 8.5 μM
unlabeled Get1-CD to initiate complex dissociation. Samples
were excited at 380 nm, and fluorescence emission at 470 nm was
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monitored. The time course for change in fluorescence (Fobsd)
was fit to Eq. S3.
Kinetics of mant-ATP dissociation from Get3. Measurements are based
on FRET between mant-ATP and a native tryptophan in Get3 (5)
using a pulse-chase setup on a stopped flow apparatus (Kintek).
A complex between mant-ATP (at 15 μM) and Get3 (1.5 μM)
was preformed by incubation for 20 min followed by addition of
either Get1 (at 2.5 μM) or excess ATP (2 mM) to initiate
complex dissociation. The time course for change in donor
(mant-ATP) fluorescence (Fobsd) was fit to Eq. S3.
Reconstitution of PLs. PLs containing Get1, Get2, or the Get1/2
complex were prepared as previously described (2) with mod-
ifications. The following mixture was assembled in a volume of
300–400 μL: 2–3 μM membrane protein, 87 mg washed and
degased biobeads (SM-2; Bio-Rad), 30 μL 20 mg/mL lipids (4:1
phosphatidylcholine:phosphatidylethanolamine), and 300 μL
reconstitution buffer (50 mM KHEPES, pH 7.4, 500 mM po-
tassium acetate, 5 mM magnesium acetate, 250 mM sucrose,
1 mM DTT, 0.25% deoxy-BigCHAP). The mixture was incubated
overnight with gentle agitation at 4 °C. For Get2-PL, additional
optimization was needed for efficient protein incorporation. The
following adjustments yielded robust reconstitution: 600-μL volume
protein/lipid mixture (at the concentrations noted above) in re-
constitution buffer was incubated with 40 mg biobeads overnight
followed by a second incubation with 87 mg freshly added biobeads
for 2 h. After biobead removal, 5 volumes cold water was added to
the reaction and then pelleted at 311,000 × g for 30 min. The re-
sulting PL-containing pellet was resuspended in 70–200 μL mem-
brane buffer (50 mMKHEPES, pH 7.4, 100 mM potassium acetate,
5 mM magnesium acetate, 250 mM sucrose, 1 mM DTT). PL
concentration was determined by SDS/PAGE with a known amount
of recombinant Get1 or Get2 protein using silver stain (Thermo).
Note that Get1 stains much more strongly than Get2 by silver stain.
PL Sedimentation Assay. For Get1-PL binding assays, 20 nM Get1-
PL or an equivalent volume of empty PL was mixed with 40 nM
Get3 or Get3/TA in Get3 assay buffer and 2 mM ATP (where
indicated) in a total volume of 150 μL. For Get2-PL binding
assays, 96 nM Get2-PL or an equivalent volume of empty PL was
mixed with 500 nM Get3 or Get3/TA in Get3 assay buffer and
2 mM ATP (optional) in a total volume of 150 μL. The reactions
were incubated for 10 min at room temperature and then ul-
tracentrifuged at 434,000 × g for 30 min. The resulting pellet was
resuspended in gel loading dye and analyzed by SDS/PAGE
and silver staining. Protein bands were quantified using Image
QuantTL (GE Healthcare). All values were subtracted from the
control with empty PL (set as zero) and normalized to the
strongest binder (set as 100%) in each dataset. Comparing Get3
with Get3/TA binding, the values obtained for Get3/TA were
multiplied by one-half to account for the fact that Get3/TA is
a tetramer, whereas Get3 is a dimeric.
Get3 Recycling Assay. Experiments using Get1-PL (Fig. 7A) were
initiated by preincubating the following mixture for 10 min at
room temperature: 100 nM Get1-PL or an equivalent volume of
empty PL, 100 nM HIS6-Get3, and ATP (at indicated concen-
trations) in a total volume of 150 μL in Get3 assay buffer. Get4/5
(at indicated concentrations) was then added for an additional
10 min, and the reaction was pelleted as described for the sed-
imentation assay. Get3 was detected by Western blotting using
an anti-His antibody (Qiagen). Experiments with yRM were
initiated by preincubating the following mixture for 10 min at
room temperature: 0.16 A280/mL Δget3 yRM, 50 nM HIS6-Get3,
and ATP (at indicated concentrations) in a total volume of 150
μL in Get3 assay buffer. Get4/5 (at indicated concentrations) was
then added for an additional 10 min, and the reaction was ul-
tracentrifuged (TLA100; 436,000 × g for 10 min). Equivalent
amounts of the soluble and pellet fractions were analyzed by
Western blot against HIS.
Kar2 Secretion Assay. Kar2 secretion assays were carried out as
described in ref. 6. For Western blot analysis, Kar2 anti-rabbit
antibody was used at 1/3,000 dilution. The protein bands were
quantified using Image QuantTL (GE Healthcare).
Insertion Assays. All in vitro translation and translocation assays
were carried out as described in ref. 5. The substrate used was
full-length yeast Sbh1 containing a C-terminal opsin tag. For the
experiments in Fig. S4, [35S]methionine-labeled Sbh1 was
translated in yeast extracts. Get3/Sbh1-opsin targeting complexes
were purified from the extract using an HIS6 tag on Get3 and
presented to 4 A280/mL yRM or PLs at indicated concentrations
for 40 min at 26 °C. Completed reactions were prechilled on ice
for 25 min and treated with 2 μL 1 mg/mL proteinase K in a 20 μL
volume for 10 min. Digestions were quenched with 5 mM
PMSF followed by resuspension in boiling 2× SDS gel loading
dye. Reactions were analyzed by SDS/PAGE and autoradiogra-
phy. For the experiments in Fig. S2, recombinant Get3 was
coexpressed with HIS6-Sbh1-opsin (5). The complex was purified
as described (5) and incubated with yRM at indicated concen-
trations in Get3 assay buffer and 4 mM ATP (if indicated) for
45 min at 26 °C. The reaction was loaded on a 50-μL sucrose
cushion (0.5 M in assay buffer) and separated into supernatant
and pellet fractions by ultracentrifugation at 434,000 × g for 30
min. Sbh1 was detected by anti-HIS Western blot, and the gly-
cosylation product was verified by Endo H treatment following
the manufacturer’s instructions (P0702; NEB).
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Fig. S1. Overlay of the binding sites of (Left) Get4 and Get2 and (Right) Get4 and Get1 on the Get3 dimer (1).
1. Gristick H, et al. (2014) Crystal structure of ATP-bound Get3-Get4-Get5 complex reveals regulation of Get3 by Get4. Nat Struct Mol Biol 21(5):437–442.
Fig. S2. Interaction of Get3 with Get4/5 (related to Fig. 1). (A) Fluorescence emission spectra of 100 nM acrylodan-labeled Get4/5 with (black) and without
(red) 500 nM Get3. (B) Multiple-turnover ATPase assay with 2.0 μM Get3 alone or in complex with 8.0 μM WT (black) or acrylodan-labeled (red) Get4(C177T,
S48C)/Get5. All assays contained 200 μM ATP. (C) Bacterially expressed recombinant Get3/HIS6-Sbh1-opsin complex was presented to yRM for insertion. (Left)
Verification of translocated (glycosylated) Sbh1-opsin band in the membrane fraction and its sensitivity to endoH treatment. (Right) Quantification of the
insertion of the recombinant Get3/HIS6-Sbh1-opsin complex into various amounts of yRMs. The yRM-associated fraction is shown (Materials and Methods). (D)
Comparison of the amount of TA inserted for the Get3/TA complex generated recombinantly (this work) and that generated by in vitro translation (1). A.U.,
arbitrary unit; Sup, supernatant.
1. Mariappan M, et al. (2011) The mechanism of membrane-associated steps in tail-anchored protein insertion. Nature 477(7362):61–66.
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Fig. S3. The interaction of Get3 with Get1-CD and Get2-CD (related to Fig. 3). (A) Fluorescence emission spectra of 150 nM DACM-labeled Get1-CD alone (red)
or in the presence of the following: 400 nM Get3 (blue), 400 nM Get3 and 2.3 mM ATP (green), or 400 nM Get3, 2.3 mM ATP, and 17 μM unlabeled Get1
(orange). (B) Pull-down assay of HIS6-tagged Get3 with (Left) untagged WT Get2-CD or Get2(T34C)-CD and (Right) untagged WT Get1-CD or Get1(Q62C)-CD.
Controls with no Get3-HIS6 are shown for comparison. (C) Summary of the fluorescence anisotropy end points for complexes of Get1-CD and Get2-CD with the
Get3/TA complex in the ADP or apo states. (D) Cartoon showing dye placement (cyan) on (Left) Get2 T34C (red; Protein Data Bank ID code 3ZS9) and (Right)
Get1 Q62C (purple; Protein Data Bank ID code 3ZS8) in their respective complexes with the Get3 dimer (yellow). A.U., arbitrary unit.
Rome et al. www.pnas.org/cgi/content/short/1411284111 4 of 7
Fig. S4. Reagents for generating Get1/2-PL (related to Fig. 5). (A) SDS/PAGE showing the purification of full-length Get1 and Get2 in detergent as described in
Materials and Methods. (B) Silver-stained gel containing Get2-PL and increasing amounts of recombinant Get2. Band intensity of Get2 in PL was quantified
using known amounts of recombinant Get2 as a standard for concentration determination. C is the same as B but with Get1-PL and Get1/2-PL. (D) Get3/Sbh1-
opsin targeting complexes labeled with 35S-Met were purified from yeast translation extract using an HIS6 tag on Get3 (Materials and Methods) and presented
to yRM, Get1/2 PLs, or empty liposomes as indicated. Insertion was analyzed by protection against proteinase K (Materials and Methods). Targeting complexes
inserted into yRMs also contained a proteinase K-resistant fragment glycosylated to 55% efficiency. Det. Sol, detergent soluble; F/T, flow-through; FL, full-
length; Glc, glycosylated; PF, protected fragment; Sup, supernatant.
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Fig. S5. Get4/5 aids in recycling Get3 from the ER membrane (related to Fig. 7). (A) Release of Get3 from yRMs by WT and mutant Get4/5. HIS6-Get3 was
preincubated with yRMs for 15 min in 4 mM ATP and chased with either WT Get4/5 or binding-deficient mutant Get4/5 (YYE). RMs were sedimented as in Fig. 5,
and HIS6-Get3 was detected by Western blot using anti-HIS antibody. (B) In vivo assay for TA targeting based on Kar2p secretion (related to Fig. 7). Western
blot of secreted Kar2p from the indicated yeast strains (WT, Δget3, Δget4, and Δsgt2) detected it using an anti-Kar2p antibody. Lower shows quantification of
the Western blot.
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Table S1. Summary of the equilibrium binding affinities of the
interaction of Get3 with Get4/5
Get4/5
construct
Get3
complex Nucleotide Kd (nM)
Full-length
Get4/5
Get3 Apo 234 ± 47
ATP 3.2 ± 2.0
Get3/TA Apo Not detectable
ATP 46 ± 4
ADP 49 ± 4
Get4/5N Get3 Apo 6.0 × 103
ATP 127 ± 6
Table S2. Summary of the kinetics of the Get3–Get4/5 association in ATP
Buffer ionic strength
First phase Second phase
k1 (μM−1 s−1) Amplitude (%) k2 (μM−1 s−1) Amplitude (%)
150 mM KOAc 144 ± 12 57 44 ± 5 43
350 mM NaCl 8.9 ± 0.4 64 33 ± 6 36
100 mM NaCl 145 ± 6 59 39 ± 4 41
No salt 272 ± 8 59 39 ± 10 41
Table S3. Summary of the kinetics of Get3 dissociation from Get4/5 in ATP
Buffer ionic strength
First phase Second phase
k−1 (s
−1) Amplitude (%) k−2 (s
−1) Amplitude (%)
150 mM KOAc 0.65 ± 0.12 49 0.10 ± 0.03 51
Table S4. Summary of the equilibrium binding affinities of the
interaction of Get3 with Get1-CD and Get2-CD
Receptor Get3 complex Nucleotide Kd (μM)
Get1 Get3 Apo 0.055 ± 0.015
ADP 0.62 ± 0.19
ATP Not detectable
Get3/TA Apo 2.50 ± 0.58
ADP 29.7 ± 4.8
ATP Not detectable
Get2 Get3 Apo 0.47 ± 0.09
ADP 0.44 ± 0.13
ATP 0.90 ± 0.17
Get3/TA Apo 1.61 ± 0.006
ADP 2.74 ± 0.003
ATP 2.77 ± 0.82
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